Prospective evaluation of the management of hepatocellular carcinoma in the elderly

Digestive and Liver Disease

Volumn 43, Issue 12, 2011, Pages 1001-1005

  Ozenne, Violaine ^a   Bouattour, Mohamed ^a   Goutté, Nathalie ^a   Vullierme, Marie Pierre ^a   Ripault, Marie Pierre ^a   Castelnau, Corinne ^a   Valla, Dominique Charles ^a   Degos, Françoise ^a   Farges, Olivier ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Anti angiogenic therapy; Liver transplantation; Radiofrequency ablation; Transarterial chemoembolization

Indexed keywords

AGED; AGING; ARTICLE; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GERIATRICS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 80055065225     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.06.019     Document Type: Article

References (26)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
2. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
3. Kiyosawa K., Umemura T., Ichijo T., et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004, 127:S17-S26.
4. Borie F., Tretarre B., Bouvier A.M., et al. Primitive liver cancers: epidemiology and geographical study in France. Eur J Gastroenterol Hepatol 2009, 21:984-989.
5. Borie F., Bouvier A.M., Herrero A., et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008, 98:505-509.
6. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421-430.
7. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
8. Kudo M., Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007, 72(Suppl. 1):2-15.
9. Nomura F., Ohnishi K., Honda M., et al. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994, 70:690-693.
10. Collier J.D., Curless R., Bassendine M.F., et al. Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Age Ageing 1994, 23:22-27.
11. Trevisani F., D'Intino P.E., Grazi G.L., et al. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996, 77:2223-2232.
12. Poon R.T., Fan S.T., Lo C.M., et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999, 94:2460-2466.
13. Hazama H., Omagari K., Matsuo I., et al. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepatogastroenterology 2001, 48:1692-1696.
14. Giannini E., Romagnoli P., Fasoli A., et al. Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma. Age Ageing 2002, 31:457-462.
15. Dohmen K., Shirahama M., Shigematsu H., et al. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2004, 19:859-865.
16. Tsukioka G., Kakizaki S., Sohara N., et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol 2006, 12:48-53.
17. Pignata S., Gallo C., Daniele B., et al. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol 2006, 59:243-249.
18. Cho S.J., Yoon J.H., Hwang S.S., et al. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?. J Gastroenterol Hepatol 2007, 22:1226-1231.
19. Mirici-Cappa F., Gramenzi A., Santi V., et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010, 59:387-396.
20. Manfredi S., Lepage C., Hatem C., et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006, 244:254-259.
21. Leporrier J., Maurel J., Chiche L., et al. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006, 93:465-474.
22. Trevisani F., Cantarini M.C., Labate A.M., et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004, 99:1470-1476.
23. Hiraoka A., Michitaka K., Horiike N., et al. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. J Gastroenterol Hepatol 2009.
24. Yau T., Yao T.J., Chan P., et al. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization. Cancer 2009, 115:5507-5515.
25. http://www.ined.fr/fr/pop_chiffres/france/mortalite_causes_deces/esperance_vie/.
26. Balducci L., Extermann M., Carreca I. Management of breast cancer in the older woman. Cancer Control 2001, 8:431-441.